Reaction
Primary Hypothyroidism reporting signals
As of the last recalculation, Primary Hypothyroidism appears in 203 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is LENVATINIB (PRR 50.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lenvatinib | 15 | 50.5 | 50.6 |
| Nivolumab | 29 | 35.7 | 35.7 |
| Ipilimumab | 14 | 35.6 | 35.7 |
| Somatropin | 14 | 20.9 | 20.9 |